Helius Medical Technologies (NASDAQ:HSDT) and CONMED (NYSE:CNMD) Financial Contrast

CONMED (NYSE:CNMD) and Helius Medical Technologies (NASDAQ:HSDT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent ratings for CONMED and Helius Medical Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	0	1	4	0	2.80
Helius Medical Technologies	0	0	1	0	3.00

CONMED currently has a consensus price target of $79.80, suggesting a potential upside of 20.38%. Helius Medical Technologies has a consensus price target of $24.00, suggesting a potential upside of 3,378.77%. Given Helius Medical Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Helius Medical Technologies is more favorable than CONMED.

Insider & Institutional Ownership

18.6% of Helius Medical Technologies shares are held by institutional investors. 6.8% of CONMED shares are held by company insiders. Comparatively, 5.1% of Helius Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares CONMED and Helius Medical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CONMED	7.73%	14.12%	5.06%
Helius Medical Technologies	-1,328.14%	-297.49%	-107.36%

Risk and Volatility

CONMED has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500.

Earnings and Valuation

This table compares CONMED and Helius Medical Technologies’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.28 billion	1.59	$64.46 million	$2.61	25.20
Helius Medical Technologies	$668,000.00	2.97	-$8.85 million	($13.04)	-0.05

CONMED has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Summary

CONMED beats Helius Medical Technologies on 9 of the 14 factors compared between the two stocks.

About CONMED

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

About Helius Medical Technologies

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.